Ribbon Biolabs

Ribbon Biolabs is a biotech company in Vienna, Austria, founded in 2018. It has raised $20.1M across 2 rounds, most recently a $20.1M Series A in 2022 (est.).

Making The Impossible Possible

Headquarters
Vienna, Vienna
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$20.1M
Last Round
$20.1M Series AJan 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Ribbon Bio is a Vienna-based synthetic biology company that produces MiroSynth™ DNA using proprietary algorithm-driven enzymatic synthesis technology. Its platform manufactures pristine, high-accuracy synthetic DNA molecules — both linear (up to 12 kb) and circular (up to 20 kb) — free of bacterial constraints, enabling next-generation mRNA, CAR-T, and gene therapy applications. Ribbon serves biopharma and synthetic biology partners worldwide.

Summary

It lists 11–50 employees. It has raised $20.1M in total across 2 rounds, most recently a $20.1M Series A round in 2022 (est.). Investors include Hadean Ventures, Lansdowne Partners and Helicase Venture.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries A2022 (est.)
$20.1M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ribbon Biolabs on Indexed.vc
<a href="https://indexed.vc/companies/ribbon-biolabs"><img src="https://indexed.vc/api/badge/company/ribbon-biolabs" alt="Ribbon Biolabs on Indexed.vc" width="260" height="76" /></a>